Indian company seeks US approval for generic AIDS drugs.
出版信息
Nature. 2004 Aug 12;430(7001):716. doi: 10.1038/430716a.
DOI:10.1038/430716a
PMID:15306779
Abstract
摘要
相似文献
1
Indian company seeks US approval for generic AIDS drugs.
Nature. 2004 Aug 12;430(7001):716. doi: 10.1038/430716a.
2
Global AIDS trial denied patients as US balks at generic drug use.
Nature. 2004 Sep 30;431(7008):493. doi: 10.1038/431493a.
3
AIDS treatment. A step toward cheaper anti-HIV therapy.
Science. 2005 Feb 4;307(5710):653. doi: 10.1126/science.307.5710.653b.
4
Generic drugs: the stalling game.
Consum Rep. 2001 Jul;66(7):36-40.
5
100th HIV/AIDS antiretroviral drug approved by PEPFAR.
AIDS Patient Care STDS. 2009 Nov;23(11):988-9.
6
WHO pulls Indian generics off AIDS drugs list.
Nat Med. 2004 Sep;10(9):885. doi: 10.1038/nm0904-885.
7
Just the medicine. Cheaper AIDS drugs.
US News World Rep. 2001 Mar 26;130(12):31.
8
Production of low cost AIDS drugs to continue in Brazil.
Reprod Health Matters. 2001 Nov;9(18):178.
9
Path to approval proves rocky for copycat biodrugs.
Nature. 2005 Nov 10;438(7065):154-5. doi: 10.1038/438154a.
10
AIDS treatment. Drugmakers test restrictions on generics in U.S. programs.
Science. 2004 Oct 8;306(5694):213. doi: 10.1126/science.306.5694.213a.
Zotero 插件